MORGAN GORDON: Open Payments
NPI 1215531181 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,112 in 44 payments from 16 companies in 2025. Trend: 2023 $870 · 2024 $1,055 · 2025 $1,112
Food & beverage: $1,112
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $311 |
| Novartis Pharmaceuticals Corporation | 5 | $140 |
| KYOWA KIRIN, INC. | 2 | $102 |
| Vifor Pharma, Inc. | 4 | $100 |
| Calliditas Therapeutics US Inc. | 2 | $63 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| Vantive US Healthcare LLC | 1 | $56 |
| Travere Therapeutics, Inc. | 2 | $51 |
| Novo Nordisk Inc | 2 | $50 |
| Lilly USA, LLC | 3 | $47 |
Products named: JYNARQUE, Veltassa, Vanrafia, TARPEYO, Renal - PD, JARDIANCE, FARXIGA, LOKELMA.
Industry payments across FL — which companies pay providers there.
